Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The patient has 18 years of age or older at the time of consent.
The patient has provided pre-treatment tumor samples for WT1 expression screening and gene expression profiling in the context of the NCT01220128 study.
The patient has a histologically or cytologically confirmed primary invasive breast cancer.
The patient has provided written informed consent before any new information or new material is provided to the Sponsor.
The patient is planned to receive, is receiving or has received standard and/or investigational therapy for breast cancer.
The patient is planned to receive, is receiving or has received standard and/or investigational therapy for breast cancer.
